stockportfolio.pro
Stocks / ALGN vs IONS
ALGN vs IONS
Align Technology, Inc. and Ionis Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Align Technology, Inc. (ALGN) | Ionis Pharmaceuticals, Inc. (IONS) | |
|---|---|---|
| Market cap | $12.8B | $12.2B |
| Revenue (latest FY) | $4.03B | $943.71M |
| Net income (latest FY) | $410.35M | $-381.39M |
| Revenue growth (5y CAGR) | 10.3% | 5.3% |
| Net margin | 10.2% | -40.4% |
| Return on equity | 10.1% | -78.0% |
| P/E ratio | 30.0 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 3 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ALGN — free Open IONS — freeFrequently asked questions
Which is bigger, ALGN or IONS?
Align Technology, Inc. is larger by market capitalization — $12.8B versus $12.2B.
Which grows faster, ALGN or IONS?
Over the last five fiscal years, Align Technology, Inc. grew revenue faster — 10.3%/yr versus 5.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.